Friday, January 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Featured News

Medical Countermeasure Nonclinical Studies Network Contract Awards

by Global Biodefense Staff
March 30, 2017
Sequencing Medical Research

The Nonclinical Studies Network is a key element in the successful development of U.S. medical countermeasures for biological threats, particularly since efficacy of products directed against most of these threats cannot be verified using clinical studies.

The U.S. government this month awarded multiple Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts to support this network of GLP laboratories to provide capabilities for nonclinical animal studies, analytical services, and toxicology services.

The following organizations were selected:

  • Battelle Memorial Institute
  • IIT Research Institute
  • Lovelace Biomedical & Environmental Research Institute
  • MRI Global
  • Public Health England
  • Southern Research Institute
  • SRI International

The effort is on behalf of the Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services, Office of the Assistant Secretary for Preparedness & Response (ASPR).

BARDA anticipates that contracts awarded from under this ID/IQ will serve to facilitate the animal model development of medical countermeasures and supportive reagents and assays for regulatory acceptance in the U.S.

Source: Solicitation Number: RFP-16-100-SOL-00008

Tags: Animal ModelsAntitoxinsAntiviralsASPRAwardsBARDABattelleHHSVaccines

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC